KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.6211
+0.0652 (11.73%)
At close: Jan 2, 2026, 4:00 PM EST
0.6225
+0.0014 (0.23%)
After-hours: Jan 2, 2026, 7:58 PM EST
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $6.66 million as of January 2, 2026. Its market cap has decreased by -76.62% in one year.
Market Cap
6.66M
Enterprise Value
15.55M
1-Year Change
-76.62%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $6.66M, a decrease of -98.45%. That is a compound annual growth rate of -38.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 956.43B |
| Johnson & Johnson | 493.59B |
| AbbVie | 404.31B |
| UnitedHealth Group | 299.34B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 260.56B |
| Novo Nordisk | 227.63B |